Weigao Group | Sustainability Performance
Manufactures medical devices and polymer-based healthcare products.
2001
China
10,001+ employees
Medical Device
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#10777
Overallⓘ#766
in Chinaⓘ#160
in Medical DeviceⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Laggard
Aligned
Intensity
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
146.6
B/M 40.4
574.8
B/M 131.5
0.5
B/M 0.4
Powered by illuminem and GIST Impact
Controversy level
- Weigao Group Medical Polymer Co Ltd, Chinese medical devices (syringes, IV sets, orthopedics), has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of medical device product quality at multiple Weigao Group production facilities, plus periodic class actions over alleged inadequate disclosure of Asian medical devices customer concentration affecting Hong Konglisted institutional shareholders.
